Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Elms Steve, Director. Officer active across 4 companies, notably Marker Therapeutics, Inc.. Aggregated, 14 filings have been recorded. Split: 2 buys · 4 sells. Total volume traded: €6.8m. Activity tracked since 8 June 2021. The latest transaction was filed on 5 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Elms Steve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
ELMS STEVE is an Administrateur at Adma Biologics, INC., Marker Therapeutics, Inc. and Zosano Pharma Corp. He has 14 filings in total, and across the sampled recent filings from 2021-06-10 to 2026-03-09, the reported aggregate amounts are EUR 128270 in buys and EUR 6628872 in sells, with the modal transaction nature listed as Attribution.